Search

Your search keyword '"Chronic obstructive lung disease -- Care and treatment"' showing total 15 results
Start Over Descriptor "Chronic obstructive lung disease -- Care and treatment" Journal business wire
15 results on '"Chronic obstructive lung disease -- Care and treatment"'

1. Now Recruiting Patients for a New FDA Oversight Trial Evaluating the Use of a Patient's Own Fat Tissue for the Treatment of Post-COVID-19 Lung Damage

Subjects
Clinical trials, Chronic obstructive lung disease -- Care and treatment, Adipose tissue, COVID-19 -- Care and treatment, Industry hiring, Business, Business, international
Abstract

Promising research leads to formal trial sponsored and funded by Tulip Medical. (tulipmedical.com) [NCT #04326036 an FDA Oversight Trial] SAN DIEGO -- Tulip Medical (a dba of Black Tie Medical, [...]

Published
2020

2. PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial

Subjects
AstraZeneca PLC -- Product development, Clinical trials, Chronic obstructive lung disease -- Care and treatment, Respiratory system agents, Pharmaceutical industry -- Product development, Business, Business, international
Abstract

Trial results published in New England Journal of Medicine WILMINGTON, Del. -- Full results from the positive Phase III ETHOS trial showed AstraZeneca's triple-combination therapy PT010 (budesonide/glycopyrronium/formoterol fumarate) demonstrated a [...]

Published
2020

3. Forthcoming and Available Therapies for Allergy, Infectious Diseases and COVID-19 - ResearchAndMarkets.com

Subjects
Reslizumab -- Forecasts and trends, Anti-infective agents -- Forecasts and trends, Marburg virus disease -- Care and treatment, Lassa fever -- Care and treatment, Benralizumab -- Forecasts and trends, Chronic obstructive lung disease -- Care and treatment, Atopic dermatitis -- Care and treatment, Communicable diseases -- Care and treatment, Medical research -- Forecasts and trends, Lopinavir -- Forecasts and trends, Omalizumab -- Forecasts and trends, COVID-19 -- Care and treatment, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Technology Breakthroughs Driving Allergy & Infectious Disease Therapy' report has been added to ResearchAndMarkets.com's offering. The current research study discusses the available countermeasures and forthcoming allergic and [...]

Published
2020

4. ALung Announces Continued Progress Towards Completion of Two Landmark Pivotal Trials

Subjects
Mortality -- Pennsylvania -- United Kingdom, Chronic obstructive lung disease -- Care and treatment, Adult respiratory distress syndrome -- Care and treatment, Death, Morbidity, Technology, Cardiovascular diseases, Respiratory insufficiency, Clinical trials, Business, Business, international
Abstract

PITTSBURGH -- ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced the recent achievement of two significant [...]

Published
2019

5. PT010 Phase III ETHOS trial met its primary endpoint in chronic obstructive pulmonary disease

Subjects
AstraZeneca PLC -- Product development, Clinical trials, Benralizumab -- Product development, Chronic obstructive lung disease -- Care and treatment, Pharmaceutical industry -- Product development, Neurophysiology, Lung diseases, Business, Business, international
Abstract

At both standard and low budesonide doses, the triple-combination therapy showed a statistically-significant reduction in the rate of moderate or severe exacerbations compared with dual-combination therapies First time the benefit [...]

Published
2019

6. ALung Announces the Achievement of a Key Milestone in the U.S. Based VENT-AVOID Trial and Continued Progress Towards Completion of the Trial

Subjects
Mortality -- Pennsylvania, Chronic obstructive lung disease -- Care and treatment, Adult respiratory distress syndrome -- Care and treatment, Death, Morbidity, Heart diseases, Technology, Cardiovascular diseases, Respiratory insufficiency, Clinical trials, Business, Business, international
Abstract

PITTSBURGH -- ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the achievement of a major [...]

Published
2019

7. Mountainside Medical Group Adds New Physicians

Subjects
Physicians, Chronic obstructive lung disease -- Care and treatment, Health care industry, Health care industry, Business, Business, international
Abstract

Pulmonologist, Endocrinologist and OB/GYN Join Multi-Specialty Group MONTCLAIR, N.J. -- Mountainside Medical Group announced today the addition of three new physicians, Pulmonologist Juhayna Davis, M.D. , Endocrinologist Anjali Grover, M.D., [...]

Published
2018

8. Chronic Obstructive Pulmonary Disease: 2018 Pipeline Highlights - ResearchAndMarkets.com

Subjects
Chronic obstructive lung disease -- Care and treatment, Company licensing agreement, Business, Business, international
Abstract

DUBLIN -- The 'Chronic Obstructive Pulmonary Disease Pipeline Highlights - 2018' report has been added to ResearchAndMarkets.com's offering. 'Chronic Obstructive Pulmonary Disease Pipeline Highlights - 2018' provides the most up-to-date [...]

Published
2018

9. Trelegy Ellipta Once-Daily Single Inhaler Triple Therapy Receives Positive Opinion from the CHMP in Europe for Appropriate Patients with COPD

Subjects
GlaxoSmithKline PLC, Chronic obstructive lung disease -- Care and treatment, Glucocorticoids, Pharmaceutical industry, Business, Business, international
Abstract

LONDON -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a [...]

Published
2017

10. GSK Files Regulatory Submission in European Union for Once-Daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD

Subjects
GlaxoSmithKline PLC, Chronic obstructive lung disease -- Care and treatment, Pharmaceutical industry, Business, Business, international, European Union
Abstract

LONDON & BRISBANE, Calif. -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced the filing by GSK of a regulatory submission with the European Medicines Agency for [...]

Published
2016

11. Smith Medical's Drug-Free Acapella[R] Choice Vibratory PEP Therapy System Shown to Reduce Hospital Length of Stay by 1 1/2 Days for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Subjects
Chronic obstructive lung disease -- Care and treatment, Medical equipment, Business, Business, international, American Thoracic Society
Abstract

MINNEAPOLIS -- Smiths Medical, a leading global medical device manufacturer, announced today that a study1 presented at the American Thoracic Society International Conference shows the acapella([R]) choice system can reduce [...]

Published
2016

12. GSK Files Regulatory Submission in US for Once-Daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD

Subjects
GlaxoSmithKline PLC -- Planning, Chronic obstructive lung disease -- Care and treatment, Pharmaceutical industry -- Planning, Company business planning, Business, Business, international
Abstract

BRISBANE, Calif. -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced the filing by GSK of a regulatory submission with the US Food and Drug Administration for [...]

Published
2016

13. ALung Technologies Forms Trial Steering Committee

Subjects
Chronic obstructive lung disease -- Care and treatment, Adult respiratory distress syndrome -- Care and treatment, Business, Business, international
Abstract

Renowned physicians will oversee landmark trial of the Hemolung RAS in patients with COPD PITTSBURGH -- ALung Technologies, Inc., a leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies [...]

Published
2016

14. Enterprise Therapeutics Announces 4 million ($5 million USD) Fundraising

Subjects
Cystic fibrosis -- Care and treatment, Chronic obstructive lung disease -- Care and treatment, Drug discovery, Business, Business, international
Abstract

BRIGHTON, England -- Enterprise Therapeutics Ltd, a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases, today announced that it has [...]

Published
2016

15. iGetBetter Expands Its Care Transition Solution with a Care Plan for COPD

Subjects
Chronic obstructive lung disease -- Care and treatment, Company business planning, Business, Business, international
Abstract

Engages Post-acute Care Patients to Help Reduce Readmissions SUDBURY, Mass. -- iGetBetter, Inc., a supplier of mobile digital health solutions for post-acute care transition and long term population health management, [...]

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results